Oscar Health, Inc. (OSCR) shares soared 5.15% in pre-market trading on Thursday, indicating strong investor interest ahead of the regular session opening.
The significant pre-market gain follows an analyst upgrade from Raymond James, which raised its rating on Oscar Health to Outperform from Market Perform and set an $18 price target. According to the research firm, the stock's relative valuation appears attractive at current levels.
Analyst upgrades typically generate positive market sentiment as they signal increased confidence in a company's future performance and potential for stock appreciation. The Outperform rating suggests Raymond James expects Oscar Health to deliver better returns than the broader market average.
Comments